Yigal Arnon & Co. has developed a specialized life sciences, pharmaceutical and medical technology practice to provide customized and professional services to clients in these industries both in Israel and globally.  Our clients range from global pharmaceutical and biotech companies, to early stage life science start-ups, as well as the underwriters, investment funds and incubators that invest in life science and medical device companies. Members of the practice Group are recognized leaders in the field, and have extensive experience with diverse pharma, life sciences, and medtech ventures and transactions. Our lawyers advise these companies from establishment through maturity, whether through sophisticated out-licensing transactions, public offerings, acquisitions or other strategic arrangements, and provide a full range services to developing and established pharmaceutical, biotech and medical technology companies. Lawyers in the Group regularly handle complex intellectual property issues that arise in the development and commercialization of technology assets, and work closely with our clients to develop creative and innovative solutions for successful commercialization strategies. 

Industries Served

The Life Sciences group works closely with innovators and companies from a broad cross-section of the industry including:

  • Generic and brand pharmaceutical companies;
  • Biotechnology companies;
  • Bio-informatics and other companies on the crossroads between lab work and computer work;
  • Medical device companies of all stages;
  • Health care service companies;
  • Health care investors, whether private funds or public companies;
  • Incubators and other “platform” companies;
  • Digital and mobile health companies;
  • Leading universities and academic centers.

Scope of Services

Our team routinely assists clients in the full range of their commercial activities during all relevant phases, including:

  • IP and technology in in-licensing transactions;
  • Strategic R&D collaborations, and out-licensing transactions with global leaders in the industry;
  • Pre-clinical and in vivo clinical trial agreements;
  • CRO, CMO and related agreements;
  • Pharmaceutical manufacturing agreements;
  • Joint ventures and commercial arrangements such as drug and device distribution and marketing agreements of diverse natures;
  • Material transfer and evaluation arrangements;
  • Diverse commercialization contracts relevant to the industry such as promotion, distribution and marketing agreements;
  • Regulatory, commercialization and compliance strategies;
  • M&A, investments and other corporate transactions involving life sciences and biotechnology companies;
  • Israeli and international tax matters;
  • Technology Transfer Offices - transfer of innovation, technology and IP from academic and medical institutional frameworks to industry, as well as the further development and commercialization of such assets;
  • Expertise in Israeli R&D Law and all related matters concerning the Israel Innovation Authority;
  • Consumer rights, product liability issues and various litigation proceedings.

Recognition

Subscribe for updates and news